Tumors and inflammatory infiltrates: Friends or foes? (original) (raw)

• Balkwill F, Mantovani A. Inflammation and cancer: Back to Virkow? Lancet 2001; 357: 539–45.
  PubMed CAS Google Scholar
• Chomez P, De Backer O, Bertrand M et al. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 2001; 61(14): 5544–51.
  PubMed CAS Google Scholar
• Wada Y, Nakashima O, Kutami R et al. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepathology 1998; 27: 407–14.
  CAS Google Scholar
• Darnell RB, DeAngelis L.M. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993; 341(8836): 21–2.
  PubMed CAS Google Scholar
• Balzar M, Winter MJ, de Boer CJ et al. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 1999; 77: 699–712.
  PubMed CAS Google Scholar
• Glennie MJ, Johnson PW, Clinical trials of antibody therapy. Immunol Today 2000; 21(8): 403–10.
  PubMed CAS Google Scholar
• Chen YT, Scanlan MJ, Sahin U et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997; 94(5): 1914–8.
  PubMed CAS Google Scholar
• Benelli R, Morini M, Carozzino F et al. Neutrophils as a key cellular target for angiostatin: Implications for regulation of angiogenesis and inflammation. Faseb J 2002; 16: 267–9 [online; Faseb J 2001; 10.1096/fj.01-0651fje].
  PubMed CAS Google Scholar
• Sciacca F, Stuerzl M, Bussolino F et al. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J Immunol 1994; 153: 4816–25.
  PubMed CAS Google Scholar
• Bussolati B, Biancone L, Cassoni P et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am J Pathol 2000; 157: 1713–25.
  PubMed CAS Google Scholar
• Strieter R, Kasahara K, Allen R et al. Human neutrophils exhibit disparate chemotactic factor gene expression. Biochem Biophys Res Commun 1990; 173: 725–30.
  PubMed CAS Google Scholar
• Gasperini S, Marchi M, Calzetti F et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 1999; 162: 4928–37.
  PubMed CAS Google Scholar
• Cassatella M, Gasperini S, Russo M, Cytokine expression and release by neutrophils. Ann NY Acad Sci 1997; 832: 233–42.
  PubMed CAS Google Scholar
• Iwasaki K, Torisu M, Fujimura T. Malignant tumor and eosinophils. Prognostic significance in gastric cancer. Cancer 1986; 58: 1321–7.
  PubMed CAS Google Scholar
• Ohashi Y, Ishibashi S, Suzuki T et al. Significance of tumor associated tissue eosinophilia and other inflammatory cell infiltrate in early esophageal squamous cell carcinoma. Anticancer Res 2000; 20: 3025–30.
  PubMed CAS Google Scholar
• Kruger-Krasagakes S, Li W, Richter G et al. Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth. Eur J Immunol 1993; 23: 992–5.
  PubMed CAS Google Scholar
• Jonjic N, Peri G, Bernasconi S et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992; 176: 1165–74.
  PubMed CAS Google Scholar
• Colombo N, Peccatori F, Paganin C et al. Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy. Int J Cancer 1992; 51: 42–6.
  PubMed CAS Google Scholar
• Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. J Exp Med 1994; 179: 1109–18.
  PubMed CAS Google Scholar
• Sallusto F, Schaerli P, Loetscher P et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998; 28: 2760–9.
  PubMed CAS Google Scholar
• Sallusto F, Palermo B, Lenig D et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999; 29: 1617–25.
  PubMed CAS Google Scholar
• Vissers J, Hartgers F, Lindhout E et al. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J Leukoc Biol 2001; 69: 785–93.
  PubMed CAS Google Scholar
• Katsenelson N, Shurin G, Bykovskaia S et al. Human small cell lung carcinoma and carcinoid tumor regulate dendritic cell maturation and function. Mol Pathol 2001; 14: 40–5.
  CAS Google Scholar
• Menetrier-Caux C, Thomachot MC, Alberti L, et al. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells. Cancer Res 2001; 61: 3096–104.
  PubMed CAS Google Scholar
• Yuan D, Wilder J, Dang T et al. Activation of B lymphocytes by NK cells. Int Immunol 1992; 4: 1373–80.
  PubMed CAS Google Scholar
• Mingari MC, Moretta A, Moretta L, Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses. Immunol Today 1998; 19: 153–7.
  PubMed CAS Google Scholar
• Joshi P, Zhou X, Cuchens M et al. Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain. J Immunol 2001; 166: 885–91.
  PubMed CAS Google Scholar
• Inngjerdingen M, Damaj B, Maghazachi A. Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001; 97: 367–75.
  PubMed CAS Google Scholar
• Mizoguchi H, O'Shea J, Longo D et al. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992; 258: 1795–8.
  PubMed CAS Google Scholar
• Mortarini R, Borri A, Tragni G et al. Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12. Cancer Res 2000; 60: 3559–68.
  PubMed CAS Google Scholar
• Lasek W, Mackiewicz A, Czajka A et al. Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice. Cancer Gene Ther 2000; 7: 1581–90.
  PubMed CAS Google Scholar
• Musiani P, Modesti A, Giovarelli M et al. Cytokines, tumour-cell death and immunogenicity: A question of choice. Immunol Today 1997; 18: 32–6.
  PubMed CAS Google Scholar
• Mantovani A, Bottazzi B, Colotta F et al. The origin and function of tumor-associated macrophages. Immunol Today 1992; 13: 265–70.
  PubMed CAS Google Scholar
• Moore RJ, Owens DM, Stamp G et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 1999; 5: 828–31.
  PubMed CAS Google Scholar
• Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996; 157: 4159–65.
  PubMed CAS Google Scholar
• Boyano M, Garcia-Vazquez M, Gardeazabal J et al. Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma. Oncology 1997; 54: 400–6.
  Article PubMed CAS Google Scholar
• Wakiyaina T, Shinohara T et al. The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer. Histol Histopathol 2001; 16: 345–51.
  Google Scholar
• Sporn M, Roberts A, Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 1992; 119: 1017–21.
  PubMed CAS Google Scholar
• Crowe M, Doetschman T, Greenhalgh D. Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol 2000; 115: 3–11.
  PubMed CAS Google Scholar
• McEarchern JA, Kobie JJ, Mack V et al. Invasion and metastasis of a mammary tumor involves TGF-beta signaling. Int J Cancer 2001; 91: 76–82.
  PubMed CAS Google Scholar
• Shah A, Lee C, TGF-beta-based immunotherapy for cancer: breaching the tumor firewall. Prostate 2000; 45: 167–72.
  PubMed CAS Google Scholar
• Fujiwara H, Hamaoka T. Antitumor and antimetastatic effects of interleukin 12. Cancer Chemother Pharmacol 1996; 38: 522–6.
  Google Scholar
• Collison K, Saleh S, Parhar R et al. Evidence for IL-12-activated Ca2+ and tyrosine signaling pathways in human neutrophils. J Immunol 1998; 161: 3737–45.
  PubMed CAS Google Scholar
• Bussolati B, Mariano F, Cignetti A et al. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. J Immunol 1998; 161: 1493–500.
  PubMed CAS Google Scholar
• Ito R, Kitadai Y, Kyo E et al. Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells. Cancer Res 1993; 53: 4102–6.
  PubMed CAS Google Scholar
• Bar-Eli M. Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 1999; 67: 12–8.
  PubMed CAS Google Scholar
• Martins-Green M, Boudreau N, Bissell M. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res 1994; 54: 4334–41.
  PubMed CAS Google Scholar
• Mantovani A. Tumor-associated macrophages in neoplastic progression: A paradigm for the in vivo function of chemokines. Lab Invest 1994; 71: 5–16.
  PubMed CAS Google Scholar
• Rollins BJ. Chemokines. Blood 1997; 90: 909–28.
  PubMed CAS Google Scholar
• Bonecchi R, Facchetti F, Dusi S et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 2000; 164: 3862–9.
  PubMed CAS Google Scholar
• Coughlin C, Salhany K, Wysocka M et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angigogenesis. J Clin Invest 1998; 101: 1441–52.
  PubMed CAS Google Scholar
• Gusella G, Musso T, Bosco M et al. IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. J Immunol 1993; 151: 2725–32.
  PubMed CAS Google Scholar
• Addison C, Daniel T, Burdick M et al. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 2000; 165: 5269–77.
  PubMed CAS Google Scholar
• Romagnani P, Annunziato F, Lasagni L et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 2001; 107: 53–63.
  PubMed CAS Google Scholar
• Feil C, Augustin H, Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun 1998; 247: 38–45.
  PubMed CAS Google Scholar
• Tachibana K, Hirota S, Iizasa H et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998; 393: 595–9.
  Google Scholar
• Salcedo R, Ponce ML, Young HA et al. Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000; 96(1): 34–40.
  PubMed CAS Google Scholar
• Benelli R, Barbero A, Ferrini S et al. Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: Implications for Tat-mediated pathogenesis. J Infect Dis 2000; 182(6): 1643–51.
  PubMed CAS Google Scholar
• Youngs S, Ali S, Taub D et al. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 1997; 71: 257–66.
  PubMed CAS Google Scholar
• Muller A, Homey B, Soto H et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50–6.
  PubMed CAS Google Scholar
• Luan J, Shattuck-Brandt R, Haghnegahdar H et al. Mechanism and biological significance of constitutive expression of MgSA/GRO chemokines in malignant melanoma tumor progression. J Leuk Biol 1997; 62: 588–97.
  CAS Google Scholar
• Proost P, De Wolf-Peeters C, Conings R et al. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol 1993; 150(3): 1000–10.
  PubMed CAS Google Scholar
• Smith D, Polverini P, Kunkel S et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994; 179: 1409–15.
  PubMed CAS Google Scholar
• Baggiolini M. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994; 55: 99–179.
  Google Scholar
• Bottazzi B, Polentarutti N, Acero R et al. Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983; 220(4593): 210–2.
  PubMed CAS Google Scholar
• Coussens LM, Tinkle CL, Hanahan D et al. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103: 481–90.
  PubMed CAS Google Scholar
• Zheng J, Ramirez V. Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex. Biochem Biophys Res Commun 1999; 261: 499–503.
  PubMed CAS Google Scholar
• Jang M, Cai L, Udeani G et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218–20.
  PubMed CAS Google Scholar
• Schnurr M, Then F, Galambos P et al. Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol 2000; 165(8): 4704–9.
  PubMed CAS Google Scholar
• Capodici C, Pillinger M, Han G et al. Integrin-dependent homotypic adhesion of neutrophils. Arachidonic acid activates Raf-1/Mek/Erk via a 5-lipoxygenase-dependent pathway. J Clin Invest 1998; 102: 165–75.
  Article PubMed CAS Google Scholar
• Richard D, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765–71.
  PubMed CAS Google Scholar
• Ekbom A, Helmick C, Zack M et al. Ulcerative colitis and colorectal cancer. N Engl J Med 1990; 323: 1228–33.
  Article PubMed CAS Google Scholar
• Roboz GJ, Dias S, Lam G et al. Arsenic trioxide induces dose-and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 2000; 96: 1525–30.
  PubMed CAS Google Scholar
• Hu G. Limited proteolysis of angiogenin by elastase is regulated by plasminogen. J Protein Chem 1997; 16: 669–79.
  PubMed CAS Google Scholar
• Di Carlo E, Comes A, Basso S et al. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. J Immunol 2000; 165(6): 3111–8.
  PubMed CAS Google Scholar
• Di Carlo E, Forni G, Lollini P et al. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001; 97(2): 339–45.
  PubMed CAS Google Scholar
• Nesbit M, Schaider H, Miller TH et al. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 2001; 166(11): 6483–90.
  PubMed CAS Google Scholar
• Riker A, Kammula U, Panelli M et al. Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes. Int J Cancer 2000; 86: 818–26.
  PubMed CAS Google Scholar
• Hadden J. The immunology and immunotherapy of breast cancer: An update. Int J Immunopharmacol 1999; 21: 79–101.
  PubMed CAS Google Scholar
• Hwang I, Nahm D, Cho S et al. Anti-T autibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer. J Cancer Res Clin Oncol 1999; 125: 582–7.
  PubMed CAS Google Scholar
• Nagoshi M, Sadanaga N, Joo H et al. Tumor-specific cytokine release by donor T cells induces an effective host anti-tumor response through recruitment of host naive antigen presenting cells. Int J Cancer 1999; 80: 308–14.
  PubMed CAS Google Scholar
• Yoong K, Afford S, Randhawa S, Hubscher S et al. Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion. Am J Pathol 1999; 154: 693–703.
  PubMed CAS Google Scholar
• Yang S, Vervaert C, Seigler H et al. Tumor cells cotransduced with B7.1 and gamma-IFN induce effective rejection of established parental tumor. Gene Ther 1999; 6: 253–62.
  PubMed CAS Google Scholar
• Porgador A, Gilboa E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 1995; 182: 255–60.
  PubMed CAS Google Scholar
• Baselga J. Herceptin((R)) Alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: Pivotal trials. Oncology 2001; 61(Suppl S2): 14–21.
  PubMed CAS Google Scholar
• James ND, Atherton PJ, Jones J et al. A phase II study of the bispecific antibody MDX-H210 (anti-HER2 × CD64) with GM-CSF in HER2+ advanced prostate cancer. Br J Cancer 2001; 85(2): 152–6.
  PubMed CAS Google Scholar
• Nakashima E, Oya A, Kubota Y et al. A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice. Pharm Res 1996; 13: 1896–901.
  PubMed CAS Google Scholar
• Tannenbaum C, Tubbs R, Armstrong D et al. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol 1998; 161: 927–32.
  PubMed CAS Google Scholar
• Dilloo D, Bacon K, Holden W et al. Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat Med 1996; 2: 1090–5.
  PubMed CAS Google Scholar
• Fujisawa N, Hayashi S, Miller E. A synthetic peptide inhibitor for alpha-chemokines inhibits the tumour growth and pulmonary metastasis of human melanoma cells in nude mice. Melanoma Res 1999; 9: 105–14.
  PubMed CAS Google Scholar
• Vane J. Suppression of intestinal polyposis by inhibition of COX-2 in Apc knockout mice. Jpn J Cancer Res 1997; 88(11): inside front cover.
• Williams CS, Luongo C, Radhika A et al. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 1996; 111(4): 1134–40.
  PubMed CAS Google Scholar
• Johnson W, Anderson K, Lazovich D et al. Association of aspirin and other NSAID use with incidence of postmenopausal breast cancer. In Proceedings of AACR, New Orleans 2001; 763.
• Mamytbekova A, Rezabek K, Kacerovska H et al. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors. Neoplasma 1986; 33: 417–21.
  PubMed CAS Google Scholar
• Elder D, Halton D, Hague A et al. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression. Clin Cancer Res 1997; 3: 1679–83.
  PubMed CAS Google Scholar
• Li M, Wu X, Xu X. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin Cancer Res 2001; 7: 1010–6.
  PubMed CAS Google Scholar
• Cao Y, Prescott S. Fatty acid CoA-ligase 4 and cyclooxygenase 2 promote carcinogenesis by lowering the intracellular level of free arachidonic acid. In Proceedings of AACR, New Orleans 2001; 591.
• Tsujii M, Kawano S, DuBois R. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336–40.
  PubMed CAS Google Scholar
• Jiang C, Ting A, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82–6.
  PubMed CAS Google Scholar
• Lefebvre A, Chen I, Desreumaux P et al. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 1998; 4: 1053–7.
  PubMed CAS Google Scholar
• He T, Chan T, Vogelstin B. PPAR delta is an APC-regulated target of nonsteroidal anti-indlammatory drugs. Cell 1999; 99: 335–45.
  PubMed CAS Google Scholar
• Yoshimura R, Sano H, Masuda C et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 2000; 89: 589–96.
  PubMed CAS Google Scholar
• Jones MK, Wang H, Peskar BM et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5(12): 1418–23.
  PubMed CAS Google Scholar
• Terris B, Baldin V, Dubois S et al. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 1995; 55: 1590–7.
  PubMed CAS Google Scholar
• Nakamoto T, Inagawa H, Takagi K et al. A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors. Anticancer Res 2000; 20(6A): 4087–96.
  PubMed CAS Google Scholar
• Vukanovic J, Isaacs J. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res 1995; 55: 1499–504.
  PubMed CAS Google Scholar
• Joseph I, Isaacs J. The antiangiogenic agent linomide inhibits tumor necrosis factor-alpha secretion via inhibition of its synthesis. Prostate 1996; 29: 183–90.
  PubMed CAS Google Scholar
• Kenyon B, Browne F, D'Amato R. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 1997; 64: 971–8.
  PubMed CAS Google Scholar
• Eisen T, Boshoff C, Mak I et al. Continuous low dose Thalidomide: A phase II study in advanced mclanoma, renal cell, ovarian and breast cancer. Br J Cancer 2000; 82: 812–7.
  PubMed CAS Google Scholar
• Couriel D, Hicks K, Giralt S et al. Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation. Curr Opin Oncol 2000; 12: 582–7.
  PubMed CAS Google Scholar
• Ueda M, Ueki M, Terai Y et al. Biological implications of growth factors on the mechanism of invasion in gynecological tumor cells. Gynecol Obstet Invest 1999; 48: 221–8.
  PubMed CAS Google Scholar
• Ye J, Ding M, Zhang X et al. On the role of hydroxyl radical and the effect of tetrandrine on nuclear factor-kappaB activation by phorbol 12-myristate 13-acetate. Ann Clin Lab Sci 2000; 30: 65–71.
  PubMed CAS Google Scholar
• Ahmad N, Gupta S, Husain MM et al. Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res 2000; 6: 1524–8.
  PubMed CAS Google Scholar
• Yang L, Lee C, Yen K. Induction of apoptosis by hydrolyzable tannins from Eugenia jambos L. on human leukemia cells. Cancer Lett 2000; 157: 65–75.
  PubMed CAS Google Scholar
• Dirsch V, Vollmar A. Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties? Biochem Pharmacol 2001; 61: 587–93.
  PubMed CAS Google Scholar
• Iizuka N, Miyamoto K, Hazama S et al. Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett 2000; 158: 35–41.
  PubMed CAS Google Scholar
• Ju D, Zheng Q, Cao X et al. Esculentoside A inhibits tumor necrosis factor, interleukin-1, and interleukin-6 production induced by lipopolysaccharide in mice. Pharmacology 1998; 56: 187–95.
  PubMed CAS Google Scholar
• Fujiki H. Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 1999; 125(11): 589–97.
  PubMed CAS Google Scholar
• Garbisa S, Biggin S, Cavallarin N et al. Tumor invasion: Molecular shears blunted by green tea. Nat Med 1999; 5(11): 1216.
  PubMed CAS Google Scholar
• Chan M, Mattiacci J, Hwang H et al. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol 2000; 60: 1539–48.
  PubMed CAS Google Scholar
• Canali R, Vignolini F, Nobili F et al. Reduction of oxidative stress and cytokine-induced neutrophil chemoattractant (CINC) expression by red wine polyphenols in zinc deficiency induced intestinal damage of rat. Free Radic Biol Med 2000; 28: 1661–70.
  PubMed CAS Google Scholar
• Damianaki A, Bakogeorgou E, Kampa M et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 2000; 78: 429–41.
  PubMed CAS Google Scholar
• Tosetti F, Ferrari N, De Flora S et al. Angioprevention: Angiogenesis is a common and key target for cancer chemopreventive agents. Faseb J 2002; 16: 2–14.
  PubMed CAS Google Scholar